Global Non-Opioid Patch Market Growth 2026-2032
The global Non-Opioid Patch market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
A Non-Opioid Patch is a transdermal patch used for pain management. Unlike opioid-based patches, non-opioid patches deliver medications that are not opioids, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or lidocaine, to provide pain relief without the risk of opioid addiction or dependence.
A Non-Opioid Patch is a medical patch or transdermal delivery system that releases medications for pain relief without containing opioids. These patches are used to manage various types of pain, such as chronic pain, post-surgery pain, or pain associated with certain medical conditions.
LP Information, Inc. (LPI) ' newest research report, the ?Non-Opioid Patch Industry Forecast? looks at past sales and reviews total world Non-Opioid Patch sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Opioid Patch sales for 2026 through 2032. With Non-Opioid Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Opioid Patch industry.
This Insight Report provides a comprehensive analysis of the global Non-Opioid Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Opioid Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Opioid Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Opioid Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Opioid Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Opioid Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
A Non-Opioid Patch is a transdermal patch used for pain management. Unlike opioid-based patches, non-opioid patches deliver medications that are not opioids, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or lidocaine, to provide pain relief without the risk of opioid addiction or dependence.
A Non-Opioid Patch is a medical patch or transdermal delivery system that releases medications for pain relief without containing opioids. These patches are used to manage various types of pain, such as chronic pain, post-surgery pain, or pain associated with certain medical conditions.
LP Information, Inc. (LPI) ' newest research report, the ?Non-Opioid Patch Industry Forecast? looks at past sales and reviews total world Non-Opioid Patch sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Opioid Patch sales for 2026 through 2032. With Non-Opioid Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Opioid Patch industry.
This Insight Report provides a comprehensive analysis of the global Non-Opioid Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Opioid Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Opioid Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Opioid Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Opioid Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Opioid Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Prescription Medicines
- OTC Medicines
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NEXGEL Advanced Hydrogel Solutions
- Viatris Inc.
- Johnson and Johnson
- Teva Pharmaceutical Industries Ltd
- Sorrento Therapeutics Inc.
- Hisamitsu Pharmaceutical Co.,Inc.
- Endo International plc.
- Purdue Pharma L.P.
- Amneal Pharmaceuticals LLC
- Grunenthal
- What is the 10-year outlook for the global Non-Opioid Patch market?
- What factors are driving Non-Opioid Patch market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Non-Opioid Patch market opportunities vary by end market size?
- How does Non-Opioid Patch break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Opioid Patch Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-Opioid Patch by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-Opioid Patch by Country/Region, 2021, 2025 & 2032
2.2 Non-Opioid Patch Segment by Type
2.2.1 Prescription Medicines
2.2.2 OTC Medicines
2.2.3 Non-Opioid Patch Sales by Type
2.2.3.1 Global Non-Opioid Patch Sales Market Share by Type (2021-2026)
2.2.3.2 Global Non-Opioid Patch Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Non-Opioid Patch Sale Price by Type (2021-2026)
2.3 Non-Opioid Patch Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Drug Stores
2.3.3 Online Pharmacies
2.3.4 Non-Opioid Patch Sales by Application
2.3.4.1 Global Non-Opioid Patch Sale Market Share by Application (2021-2026)
2.3.4.2 Global Non-Opioid Patch Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Non-Opioid Patch Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-Opioid Patch Breakdown Data by Company
3.1.1 Global Non-Opioid Patch Annual Sales by Company (2021-2026)
3.1.2 Global Non-Opioid Patch Sales Market Share by Company (2021-2026)
3.2 Global Non-Opioid Patch Annual Revenue by Company (2021-2026)
3.2.1 Global Non-Opioid Patch Revenue by Company (2021-2026)
3.2.2 Global Non-Opioid Patch Revenue Market Share by Company (2021-2026)
3.3 Global Non-Opioid Patch Sale Price by Company
3.4 Key Manufacturers Non-Opioid Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Opioid Patch Product Location Distribution
3.4.2 Players Non-Opioid Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-OPIOID PATCH BY GEOGRAPHIC REGION
4.1 World Historic Non-Opioid Patch Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-Opioid Patch Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-Opioid Patch Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-Opioid Patch Market Size by Country/Region (2021-2026)
4.2.1 Global Non-Opioid Patch Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-Opioid Patch Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Opioid Patch Sales Growth
4.4 APAC Non-Opioid Patch Sales Growth
4.5 Europe Non-Opioid Patch Sales Growth
4.6 Middle East & Africa Non-Opioid Patch Sales Growth
5 AMERICAS
5.1 Americas Non-Opioid Patch Sales by Country
5.1.1 Americas Non-Opioid Patch Sales by Country (2021-2026)
5.1.2 Americas Non-Opioid Patch Revenue by Country (2021-2026)
5.2 Americas Non-Opioid Patch Sales by Type (2021-2026)
5.3 Americas Non-Opioid Patch Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Opioid Patch Sales by Region
6.1.1 APAC Non-Opioid Patch Sales by Region (2021-2026)
6.1.2 APAC Non-Opioid Patch Revenue by Region (2021-2026)
6.2 APAC Non-Opioid Patch Sales by Type (2021-2026)
6.3 APAC Non-Opioid Patch Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-Opioid Patch by Country
7.1.1 Europe Non-Opioid Patch Sales by Country (2021-2026)
7.1.2 Europe Non-Opioid Patch Revenue by Country (2021-2026)
7.2 Europe Non-Opioid Patch Sales by Type (2021-2026)
7.3 Europe Non-Opioid Patch Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Opioid Patch by Country
8.1.1 Middle East & Africa Non-Opioid Patch Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-Opioid Patch Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-Opioid Patch Sales by Type (2021-2026)
8.3 Middle East & Africa Non-Opioid Patch Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Opioid Patch
10.3 Manufacturing Process Analysis of Non-Opioid Patch
10.4 Industry Chain Structure of Non-Opioid Patch
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Opioid Patch Distributors
11.3 Non-Opioid Patch Customer
12 WORLD FORECAST REVIEW FOR NON-OPIOID PATCH BY GEOGRAPHIC REGION
12.1 Global Non-Opioid Patch Market Size Forecast by Region
12.1.1 Global Non-Opioid Patch Forecast by Region (2027-2032)
12.1.2 Global Non-Opioid Patch Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-Opioid Patch Forecast by Type (2027-2032)
12.7 Global Non-Opioid Patch Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 NEXGEL Advanced Hydrogel Solutions
13.1.1 NEXGEL Advanced Hydrogel Solutions Company Information
13.1.2 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolios and Specifications
13.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 NEXGEL Advanced Hydrogel Solutions Main Business Overview
13.1.5 NEXGEL Advanced Hydrogel Solutions Latest Developments
13.2 Viatris Inc.
13.2.1 Viatris Inc. Company Information
13.2.2 Viatris Inc. Non-Opioid Patch Product Portfolios and Specifications
13.2.3 Viatris Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Viatris Inc. Main Business Overview
13.2.5 Viatris Inc. Latest Developments
13.3 Johnson and Johnson
13.3.1 Johnson and Johnson Company Information
13.3.2 Johnson and Johnson Non-Opioid Patch Product Portfolios and Specifications
13.3.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson and Johnson Main Business Overview
13.3.5 Johnson and Johnson Latest Developments
13.4 Teva Pharmaceutical Industries Ltd
13.4.1 Teva Pharmaceutical Industries Ltd Company Information
13.4.2 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.4.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.5 Sorrento Therapeutics Inc.
13.5.1 Sorrento Therapeutics Inc. Company Information
13.5.2 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolios and Specifications
13.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sorrento Therapeutics Inc. Main Business Overview
13.5.5 Sorrento Therapeutics Inc. Latest Developments
13.6 Hisamitsu Pharmaceutical Co.,Inc.
13.6.1 Hisamitsu Pharmaceutical Co.,Inc. Company Information
13.6.2 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolios and Specifications
13.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hisamitsu Pharmaceutical Co.,Inc. Main Business Overview
13.6.5 Hisamitsu Pharmaceutical Co.,Inc. Latest Developments
13.7 Endo International plc.
13.7.1 Endo International plc. Company Information
13.7.2 Endo International plc. Non-Opioid Patch Product Portfolios and Specifications
13.7.3 Endo International plc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Endo International plc. Main Business Overview
13.7.5 Endo International plc. Latest Developments
13.8 Purdue Pharma L.P.
13.8.1 Purdue Pharma L.P. Company Information
13.8.2 Purdue Pharma L.P. Non-Opioid Patch Product Portfolios and Specifications
13.8.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Purdue Pharma L.P. Main Business Overview
13.8.5 Purdue Pharma L.P. Latest Developments
13.9 Amneal Pharmaceuticals LLC
13.9.1 Amneal Pharmaceuticals LLC Company Information
13.9.2 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolios and Specifications
13.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Amneal Pharmaceuticals LLC Main Business Overview
13.9.5 Amneal Pharmaceuticals LLC Latest Developments
13.10 Grunenthal
13.10.1 Grunenthal Company Information
13.10.2 Grunenthal Non-Opioid Patch Product Portfolios and Specifications
13.10.3 Grunenthal Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Grunenthal Main Business Overview
13.10.5 Grunenthal Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Opioid Patch Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-Opioid Patch by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-Opioid Patch by Country/Region, 2021, 2025 & 2032
2.2 Non-Opioid Patch Segment by Type
2.2.1 Prescription Medicines
2.2.2 OTC Medicines
2.2.3 Non-Opioid Patch Sales by Type
2.2.3.1 Global Non-Opioid Patch Sales Market Share by Type (2021-2026)
2.2.3.2 Global Non-Opioid Patch Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Non-Opioid Patch Sale Price by Type (2021-2026)
2.3 Non-Opioid Patch Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Drug Stores
2.3.3 Online Pharmacies
2.3.4 Non-Opioid Patch Sales by Application
2.3.4.1 Global Non-Opioid Patch Sale Market Share by Application (2021-2026)
2.3.4.2 Global Non-Opioid Patch Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Non-Opioid Patch Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-Opioid Patch Breakdown Data by Company
3.1.1 Global Non-Opioid Patch Annual Sales by Company (2021-2026)
3.1.2 Global Non-Opioid Patch Sales Market Share by Company (2021-2026)
3.2 Global Non-Opioid Patch Annual Revenue by Company (2021-2026)
3.2.1 Global Non-Opioid Patch Revenue by Company (2021-2026)
3.2.2 Global Non-Opioid Patch Revenue Market Share by Company (2021-2026)
3.3 Global Non-Opioid Patch Sale Price by Company
3.4 Key Manufacturers Non-Opioid Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Opioid Patch Product Location Distribution
3.4.2 Players Non-Opioid Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-OPIOID PATCH BY GEOGRAPHIC REGION
4.1 World Historic Non-Opioid Patch Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-Opioid Patch Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-Opioid Patch Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-Opioid Patch Market Size by Country/Region (2021-2026)
4.2.1 Global Non-Opioid Patch Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-Opioid Patch Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Opioid Patch Sales Growth
4.4 APAC Non-Opioid Patch Sales Growth
4.5 Europe Non-Opioid Patch Sales Growth
4.6 Middle East & Africa Non-Opioid Patch Sales Growth
5 AMERICAS
5.1 Americas Non-Opioid Patch Sales by Country
5.1.1 Americas Non-Opioid Patch Sales by Country (2021-2026)
5.1.2 Americas Non-Opioid Patch Revenue by Country (2021-2026)
5.2 Americas Non-Opioid Patch Sales by Type (2021-2026)
5.3 Americas Non-Opioid Patch Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Opioid Patch Sales by Region
6.1.1 APAC Non-Opioid Patch Sales by Region (2021-2026)
6.1.2 APAC Non-Opioid Patch Revenue by Region (2021-2026)
6.2 APAC Non-Opioid Patch Sales by Type (2021-2026)
6.3 APAC Non-Opioid Patch Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-Opioid Patch by Country
7.1.1 Europe Non-Opioid Patch Sales by Country (2021-2026)
7.1.2 Europe Non-Opioid Patch Revenue by Country (2021-2026)
7.2 Europe Non-Opioid Patch Sales by Type (2021-2026)
7.3 Europe Non-Opioid Patch Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Opioid Patch by Country
8.1.1 Middle East & Africa Non-Opioid Patch Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-Opioid Patch Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-Opioid Patch Sales by Type (2021-2026)
8.3 Middle East & Africa Non-Opioid Patch Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Opioid Patch
10.3 Manufacturing Process Analysis of Non-Opioid Patch
10.4 Industry Chain Structure of Non-Opioid Patch
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Opioid Patch Distributors
11.3 Non-Opioid Patch Customer
12 WORLD FORECAST REVIEW FOR NON-OPIOID PATCH BY GEOGRAPHIC REGION
12.1 Global Non-Opioid Patch Market Size Forecast by Region
12.1.1 Global Non-Opioid Patch Forecast by Region (2027-2032)
12.1.2 Global Non-Opioid Patch Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-Opioid Patch Forecast by Type (2027-2032)
12.7 Global Non-Opioid Patch Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 NEXGEL Advanced Hydrogel Solutions
13.1.1 NEXGEL Advanced Hydrogel Solutions Company Information
13.1.2 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolios and Specifications
13.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 NEXGEL Advanced Hydrogel Solutions Main Business Overview
13.1.5 NEXGEL Advanced Hydrogel Solutions Latest Developments
13.2 Viatris Inc.
13.2.1 Viatris Inc. Company Information
13.2.2 Viatris Inc. Non-Opioid Patch Product Portfolios and Specifications
13.2.3 Viatris Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Viatris Inc. Main Business Overview
13.2.5 Viatris Inc. Latest Developments
13.3 Johnson and Johnson
13.3.1 Johnson and Johnson Company Information
13.3.2 Johnson and Johnson Non-Opioid Patch Product Portfolios and Specifications
13.3.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson and Johnson Main Business Overview
13.3.5 Johnson and Johnson Latest Developments
13.4 Teva Pharmaceutical Industries Ltd
13.4.1 Teva Pharmaceutical Industries Ltd Company Information
13.4.2 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.4.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.5 Sorrento Therapeutics Inc.
13.5.1 Sorrento Therapeutics Inc. Company Information
13.5.2 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolios and Specifications
13.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sorrento Therapeutics Inc. Main Business Overview
13.5.5 Sorrento Therapeutics Inc. Latest Developments
13.6 Hisamitsu Pharmaceutical Co.,Inc.
13.6.1 Hisamitsu Pharmaceutical Co.,Inc. Company Information
13.6.2 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolios and Specifications
13.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hisamitsu Pharmaceutical Co.,Inc. Main Business Overview
13.6.5 Hisamitsu Pharmaceutical Co.,Inc. Latest Developments
13.7 Endo International plc.
13.7.1 Endo International plc. Company Information
13.7.2 Endo International plc. Non-Opioid Patch Product Portfolios and Specifications
13.7.3 Endo International plc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Endo International plc. Main Business Overview
13.7.5 Endo International plc. Latest Developments
13.8 Purdue Pharma L.P.
13.8.1 Purdue Pharma L.P. Company Information
13.8.2 Purdue Pharma L.P. Non-Opioid Patch Product Portfolios and Specifications
13.8.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Purdue Pharma L.P. Main Business Overview
13.8.5 Purdue Pharma L.P. Latest Developments
13.9 Amneal Pharmaceuticals LLC
13.9.1 Amneal Pharmaceuticals LLC Company Information
13.9.2 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolios and Specifications
13.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Amneal Pharmaceuticals LLC Main Business Overview
13.9.5 Amneal Pharmaceuticals LLC Latest Developments
13.10 Grunenthal
13.10.1 Grunenthal Company Information
13.10.2 Grunenthal Non-Opioid Patch Product Portfolios and Specifications
13.10.3 Grunenthal Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Grunenthal Main Business Overview
13.10.5 Grunenthal Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-Opioid Patch Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-Opioid Patch Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prescription Medicines
Table 4. Major Players of OTC Medicines
Table 5. Global Non-Opioid Patch Sales by Type (2021-2026) & (K Units)
Table 6. Global Non-Opioid Patch Sales Market Share by Type (2021-2026)
Table 7. Global Non-Opioid Patch Revenue by Type (2021-2026) & ($ million)
Table 8. Global Non-Opioid Patch Revenue Market Share by Type (2021-2026)
Table 9. Global Non-Opioid Patch Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Non-Opioid Patch Sale by Application (2021-2026) & (K Units)
Table 11. Global Non-Opioid Patch Sale Market Share by Application (2021-2026)
Table 12. Global Non-Opioid Patch Revenue by Application (2021-2026) & ($ million)
Table 13. Global Non-Opioid Patch Revenue Market Share by Application (2021-2026)
Table 14. Global Non-Opioid Patch Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Non-Opioid Patch Sales by Company (2021-2026) & (K Units)
Table 16. Global Non-Opioid Patch Sales Market Share by Company (2021-2026)
Table 17. Global Non-Opioid Patch Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Non-Opioid Patch Revenue Market Share by Company (2021-2026)
Table 19. Global Non-Opioid Patch Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Non-Opioid Patch Producing Area Distribution and Sales Area
Table 21. Players Non-Opioid Patch Products Offered
Table 22. Non-Opioid Patch Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Non-Opioid Patch Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Non-Opioid Patch Sales Market Share Geographic Region (2021-2026)
Table 27. Global Non-Opioid Patch Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Non-Opioid Patch Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Non-Opioid Patch Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Non-Opioid Patch Sales Market Share by Country/Region (2021-2026)
Table 31. Global Non-Opioid Patch Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Non-Opioid Patch Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Non-Opioid Patch Sales by Country (2021-2026) & (K Units)
Table 34. Americas Non-Opioid Patch Sales Market Share by Country (2021-2026)
Table 35. Americas Non-Opioid Patch Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Non-Opioid Patch Sales by Type (2021-2026) & (K Units)
Table 37. Americas Non-Opioid Patch Sales by Application (2021-2026) & (K Units)
Table 38. APAC Non-Opioid Patch Sales by Region (2021-2026) & (K Units)
Table 39. APAC Non-Opioid Patch Sales Market Share by Region (2021-2026)
Table 40. APAC Non-Opioid Patch Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Non-Opioid Patch Sales by Type (2021-2026) & (K Units)
Table 42. APAC Non-Opioid Patch Sales by Application (2021-2026) & (K Units)
Table 43. Europe Non-Opioid Patch Sales by Country (2021-2026) & (K Units)
Table 44. Europe Non-Opioid Patch Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Non-Opioid Patch Sales by Type (2021-2026) & (K Units)
Table 46. Europe Non-Opioid Patch Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Non-Opioid Patch Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Non-Opioid Patch Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Non-Opioid Patch Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Non-Opioid Patch Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Non-Opioid Patch
Table 52. Key Market Challenges & Risks of Non-Opioid Patch
Table 53. Key Industry Trends of Non-Opioid Patch
Table 54. Non-Opioid Patch Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Non-Opioid Patch Distributors List
Table 57. Non-Opioid Patch Customer List
Table 58. Global Non-Opioid Patch Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Non-Opioid Patch Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Non-Opioid Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Non-Opioid Patch Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Non-Opioid Patch Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Non-Opioid Patch Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Non-Opioid Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Non-Opioid Patch Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Non-Opioid Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Non-Opioid Patch Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Non-Opioid Patch Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Non-Opioid Patch Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Non-Opioid Patch Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Non-Opioid Patch Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. NEXGEL Advanced Hydrogel Solutions Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 73. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolios and Specifications
Table 74. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. NEXGEL Advanced Hydrogel Solutions Main Business
Table 76. NEXGEL Advanced Hydrogel Solutions Latest Developments
Table 77. Viatris Inc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 78. Viatris Inc. Non-Opioid Patch Product Portfolios and Specifications
Table 79. Viatris Inc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Viatris Inc. Main Business
Table 81. Viatris Inc. Latest Developments
Table 82. Johnson and Johnson Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 83. Johnson and Johnson Non-Opioid Patch Product Portfolios and Specifications
Table 84. Johnson and Johnson Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Johnson and Johnson Main Business
Table 86. Johnson and Johnson Latest Developments
Table 87. Teva Pharmaceutical Industries Ltd Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 88. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolios and Specifications
Table 89. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Teva Pharmaceutical Industries Ltd Main Business
Table 91. Teva Pharmaceutical Industries Ltd Latest Developments
Table 92. Sorrento Therapeutics Inc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 93. Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolios and Specifications
Table 94. Sorrento Therapeutics Inc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sorrento Therapeutics Inc. Main Business
Table 96. Sorrento Therapeutics Inc. Latest Developments
Table 97. Hisamitsu Pharmaceutical Co.,Inc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 98. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolios and Specifications
Table 99. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Hisamitsu Pharmaceutical Co.,Inc. Main Business
Table 101. Hisamitsu Pharmaceutical Co.,Inc. Latest Developments
Table 102. Endo International plc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 103. Endo International plc. Non-Opioid Patch Product Portfolios and Specifications
Table 104. Endo International plc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Endo International plc. Main Business
Table 106. Endo International plc. Latest Developments
Table 107. Purdue Pharma L.P. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 108. Purdue Pharma L.P. Non-Opioid Patch Product Portfolios and Specifications
Table 109. Purdue Pharma L.P. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Purdue Pharma L.P. Main Business
Table 111. Purdue Pharma L.P. Latest Developments
Table 112. Amneal Pharmaceuticals LLC Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 113. Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolios and Specifications
Table 114. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Amneal Pharmaceuticals LLC Main Business
Table 116. Amneal Pharmaceuticals LLC Latest Developments
Table 117. Grunenthal Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 118. Grunenthal Non-Opioid Patch Product Portfolios and Specifications
Table 119. Grunenthal Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Grunenthal Main Business
Table 121. Grunenthal Latest Developments
Table 1. Non-Opioid Patch Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-Opioid Patch Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prescription Medicines
Table 4. Major Players of OTC Medicines
Table 5. Global Non-Opioid Patch Sales by Type (2021-2026) & (K Units)
Table 6. Global Non-Opioid Patch Sales Market Share by Type (2021-2026)
Table 7. Global Non-Opioid Patch Revenue by Type (2021-2026) & ($ million)
Table 8. Global Non-Opioid Patch Revenue Market Share by Type (2021-2026)
Table 9. Global Non-Opioid Patch Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Non-Opioid Patch Sale by Application (2021-2026) & (K Units)
Table 11. Global Non-Opioid Patch Sale Market Share by Application (2021-2026)
Table 12. Global Non-Opioid Patch Revenue by Application (2021-2026) & ($ million)
Table 13. Global Non-Opioid Patch Revenue Market Share by Application (2021-2026)
Table 14. Global Non-Opioid Patch Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Non-Opioid Patch Sales by Company (2021-2026) & (K Units)
Table 16. Global Non-Opioid Patch Sales Market Share by Company (2021-2026)
Table 17. Global Non-Opioid Patch Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Non-Opioid Patch Revenue Market Share by Company (2021-2026)
Table 19. Global Non-Opioid Patch Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Non-Opioid Patch Producing Area Distribution and Sales Area
Table 21. Players Non-Opioid Patch Products Offered
Table 22. Non-Opioid Patch Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Non-Opioid Patch Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Non-Opioid Patch Sales Market Share Geographic Region (2021-2026)
Table 27. Global Non-Opioid Patch Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Non-Opioid Patch Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Non-Opioid Patch Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Non-Opioid Patch Sales Market Share by Country/Region (2021-2026)
Table 31. Global Non-Opioid Patch Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Non-Opioid Patch Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Non-Opioid Patch Sales by Country (2021-2026) & (K Units)
Table 34. Americas Non-Opioid Patch Sales Market Share by Country (2021-2026)
Table 35. Americas Non-Opioid Patch Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Non-Opioid Patch Sales by Type (2021-2026) & (K Units)
Table 37. Americas Non-Opioid Patch Sales by Application (2021-2026) & (K Units)
Table 38. APAC Non-Opioid Patch Sales by Region (2021-2026) & (K Units)
Table 39. APAC Non-Opioid Patch Sales Market Share by Region (2021-2026)
Table 40. APAC Non-Opioid Patch Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Non-Opioid Patch Sales by Type (2021-2026) & (K Units)
Table 42. APAC Non-Opioid Patch Sales by Application (2021-2026) & (K Units)
Table 43. Europe Non-Opioid Patch Sales by Country (2021-2026) & (K Units)
Table 44. Europe Non-Opioid Patch Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Non-Opioid Patch Sales by Type (2021-2026) & (K Units)
Table 46. Europe Non-Opioid Patch Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Non-Opioid Patch Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Non-Opioid Patch Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Non-Opioid Patch Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Non-Opioid Patch Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Non-Opioid Patch
Table 52. Key Market Challenges & Risks of Non-Opioid Patch
Table 53. Key Industry Trends of Non-Opioid Patch
Table 54. Non-Opioid Patch Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Non-Opioid Patch Distributors List
Table 57. Non-Opioid Patch Customer List
Table 58. Global Non-Opioid Patch Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Non-Opioid Patch Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Non-Opioid Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Non-Opioid Patch Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Non-Opioid Patch Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Non-Opioid Patch Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Non-Opioid Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Non-Opioid Patch Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Non-Opioid Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Non-Opioid Patch Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Non-Opioid Patch Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Non-Opioid Patch Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Non-Opioid Patch Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Non-Opioid Patch Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. NEXGEL Advanced Hydrogel Solutions Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 73. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolios and Specifications
Table 74. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. NEXGEL Advanced Hydrogel Solutions Main Business
Table 76. NEXGEL Advanced Hydrogel Solutions Latest Developments
Table 77. Viatris Inc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 78. Viatris Inc. Non-Opioid Patch Product Portfolios and Specifications
Table 79. Viatris Inc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Viatris Inc. Main Business
Table 81. Viatris Inc. Latest Developments
Table 82. Johnson and Johnson Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 83. Johnson and Johnson Non-Opioid Patch Product Portfolios and Specifications
Table 84. Johnson and Johnson Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Johnson and Johnson Main Business
Table 86. Johnson and Johnson Latest Developments
Table 87. Teva Pharmaceutical Industries Ltd Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 88. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolios and Specifications
Table 89. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Teva Pharmaceutical Industries Ltd Main Business
Table 91. Teva Pharmaceutical Industries Ltd Latest Developments
Table 92. Sorrento Therapeutics Inc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 93. Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolios and Specifications
Table 94. Sorrento Therapeutics Inc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sorrento Therapeutics Inc. Main Business
Table 96. Sorrento Therapeutics Inc. Latest Developments
Table 97. Hisamitsu Pharmaceutical Co.,Inc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 98. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolios and Specifications
Table 99. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Hisamitsu Pharmaceutical Co.,Inc. Main Business
Table 101. Hisamitsu Pharmaceutical Co.,Inc. Latest Developments
Table 102. Endo International plc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 103. Endo International plc. Non-Opioid Patch Product Portfolios and Specifications
Table 104. Endo International plc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Endo International plc. Main Business
Table 106. Endo International plc. Latest Developments
Table 107. Purdue Pharma L.P. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 108. Purdue Pharma L.P. Non-Opioid Patch Product Portfolios and Specifications
Table 109. Purdue Pharma L.P. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Purdue Pharma L.P. Main Business
Table 111. Purdue Pharma L.P. Latest Developments
Table 112. Amneal Pharmaceuticals LLC Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 113. Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolios and Specifications
Table 114. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Amneal Pharmaceuticals LLC Main Business
Table 116. Amneal Pharmaceuticals LLC Latest Developments
Table 117. Grunenthal Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 118. Grunenthal Non-Opioid Patch Product Portfolios and Specifications
Table 119. Grunenthal Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Grunenthal Main Business
Table 121. Grunenthal Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-Opioid Patch
Figure 2. Non-Opioid Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-Opioid Patch Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Non-Opioid Patch Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-Opioid Patch Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-Opioid Patch Sales Market Share by Country/Region (2025)
Figure 10. Non-Opioid Patch Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Prescription Medicines
Figure 12. Product Picture of OTC Medicines
Figure 13. Global Non-Opioid Patch Sales Market Share by Type in 2026
Figure 14. Global Non-Opioid Patch Revenue Market Share by Type (2021-2026)
Figure 15. Non-Opioid Patch Consumed in Hospital Pharmacies
Figure 16. Global Non-Opioid Patch Market: Hospital Pharmacies (2021-2026) & (K Units)
Figure 17. Non-Opioid Patch Consumed in Drug Stores
Figure 18. Global Non-Opioid Patch Market: Drug Stores (2021-2026) & (K Units)
Figure 19. Non-Opioid Patch Consumed in Online Pharmacies
Figure 20. Global Non-Opioid Patch Market: Online Pharmacies (2021-2026) & (K Units)
Figure 21. Global Non-Opioid Patch Sale Market Share by Application (2025)
Figure 22. Global Non-Opioid Patch Revenue Market Share by Application in 2026
Figure 23. Non-Opioid Patch Sales by Company in 2026 (K Units)
Figure 24. Global Non-Opioid Patch Sales Market Share by Company in 2026
Figure 25. Non-Opioid Patch Revenue by Company in 2026 ($ millions)
Figure 26. Global Non-Opioid Patch Revenue Market Share by Company in 2026
Figure 27. Global Non-Opioid Patch Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Non-Opioid Patch Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Non-Opioid Patch Sales 2021-2026 (K Units)
Figure 30. Americas Non-Opioid Patch Revenue 2021-2026 ($ millions)
Figure 31. APAC Non-Opioid Patch Sales 2021-2026 (K Units)
Figure 32. APAC Non-Opioid Patch Revenue 2021-2026 ($ millions)
Figure 33. Europe Non-Opioid Patch Sales 2021-2026 (K Units)
Figure 34. Europe Non-Opioid Patch Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Non-Opioid Patch Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Non-Opioid Patch Revenue 2021-2026 ($ millions)
Figure 37. Americas Non-Opioid Patch Sales Market Share by Country in 2026
Figure 38. Americas Non-Opioid Patch Revenue Market Share by Country (2021-2026)
Figure 39. Americas Non-Opioid Patch Sales Market Share by Type (2021-2026)
Figure 40. Americas Non-Opioid Patch Sales Market Share by Application (2021-2026)
Figure 41. United States Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Non-Opioid Patch Sales Market Share by Region in 2026
Figure 46. APAC Non-Opioid Patch Revenue Market Share by Region (2021-2026)
Figure 47. APAC Non-Opioid Patch Sales Market Share by Type (2021-2026)
Figure 48. APAC Non-Opioid Patch Sales Market Share by Application (2021-2026)
Figure 49. China Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 53. India Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Non-Opioid Patch Sales Market Share by Country in 2026
Figure 57. Europe Non-Opioid Patch Revenue Market Share by Country (2021-2026)
Figure 58. Europe Non-Opioid Patch Sales Market Share by Type (2021-2026)
Figure 59. Europe Non-Opioid Patch Sales Market Share by Application (2021-2026)
Figure 60. Germany Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 61. France Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Non-Opioid Patch Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Non-Opioid Patch Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Non-Opioid Patch Sales Market Share by Application (2021-2026)
Figure 68. Egypt Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Non-Opioid Patch in 2026
Figure 74. Manufacturing Process Analysis of Non-Opioid Patch
Figure 75. Industry Chain Structure of Non-Opioid Patch
Figure 76. Channels of Distribution
Figure 77. Global Non-Opioid Patch Sales Market Forecast by Region (2027-2032)
Figure 78. Global Non-Opioid Patch Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Non-Opioid Patch Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Non-Opioid Patch Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Non-Opioid Patch Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Non-Opioid Patch Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Non-Opioid Patch
Figure 2. Non-Opioid Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-Opioid Patch Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Non-Opioid Patch Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-Opioid Patch Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-Opioid Patch Sales Market Share by Country/Region (2025)
Figure 10. Non-Opioid Patch Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Prescription Medicines
Figure 12. Product Picture of OTC Medicines
Figure 13. Global Non-Opioid Patch Sales Market Share by Type in 2026
Figure 14. Global Non-Opioid Patch Revenue Market Share by Type (2021-2026)
Figure 15. Non-Opioid Patch Consumed in Hospital Pharmacies
Figure 16. Global Non-Opioid Patch Market: Hospital Pharmacies (2021-2026) & (K Units)
Figure 17. Non-Opioid Patch Consumed in Drug Stores
Figure 18. Global Non-Opioid Patch Market: Drug Stores (2021-2026) & (K Units)
Figure 19. Non-Opioid Patch Consumed in Online Pharmacies
Figure 20. Global Non-Opioid Patch Market: Online Pharmacies (2021-2026) & (K Units)
Figure 21. Global Non-Opioid Patch Sale Market Share by Application (2025)
Figure 22. Global Non-Opioid Patch Revenue Market Share by Application in 2026
Figure 23. Non-Opioid Patch Sales by Company in 2026 (K Units)
Figure 24. Global Non-Opioid Patch Sales Market Share by Company in 2026
Figure 25. Non-Opioid Patch Revenue by Company in 2026 ($ millions)
Figure 26. Global Non-Opioid Patch Revenue Market Share by Company in 2026
Figure 27. Global Non-Opioid Patch Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Non-Opioid Patch Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Non-Opioid Patch Sales 2021-2026 (K Units)
Figure 30. Americas Non-Opioid Patch Revenue 2021-2026 ($ millions)
Figure 31. APAC Non-Opioid Patch Sales 2021-2026 (K Units)
Figure 32. APAC Non-Opioid Patch Revenue 2021-2026 ($ millions)
Figure 33. Europe Non-Opioid Patch Sales 2021-2026 (K Units)
Figure 34. Europe Non-Opioid Patch Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Non-Opioid Patch Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Non-Opioid Patch Revenue 2021-2026 ($ millions)
Figure 37. Americas Non-Opioid Patch Sales Market Share by Country in 2026
Figure 38. Americas Non-Opioid Patch Revenue Market Share by Country (2021-2026)
Figure 39. Americas Non-Opioid Patch Sales Market Share by Type (2021-2026)
Figure 40. Americas Non-Opioid Patch Sales Market Share by Application (2021-2026)
Figure 41. United States Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Non-Opioid Patch Sales Market Share by Region in 2026
Figure 46. APAC Non-Opioid Patch Revenue Market Share by Region (2021-2026)
Figure 47. APAC Non-Opioid Patch Sales Market Share by Type (2021-2026)
Figure 48. APAC Non-Opioid Patch Sales Market Share by Application (2021-2026)
Figure 49. China Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 53. India Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Non-Opioid Patch Sales Market Share by Country in 2026
Figure 57. Europe Non-Opioid Patch Revenue Market Share by Country (2021-2026)
Figure 58. Europe Non-Opioid Patch Sales Market Share by Type (2021-2026)
Figure 59. Europe Non-Opioid Patch Sales Market Share by Application (2021-2026)
Figure 60. Germany Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 61. France Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Non-Opioid Patch Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Non-Opioid Patch Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Non-Opioid Patch Sales Market Share by Application (2021-2026)
Figure 68. Egypt Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Non-Opioid Patch Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Non-Opioid Patch in 2026
Figure 74. Manufacturing Process Analysis of Non-Opioid Patch
Figure 75. Industry Chain Structure of Non-Opioid Patch
Figure 76. Channels of Distribution
Figure 77. Global Non-Opioid Patch Sales Market Forecast by Region (2027-2032)
Figure 78. Global Non-Opioid Patch Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Non-Opioid Patch Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Non-Opioid Patch Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Non-Opioid Patch Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Non-Opioid Patch Revenue Market Share Forecast by Application (2027-2032)
